Search - tctmd.com

Displaying 561 - 580 of 610

Sort: Relevancy | Date

News Conference News

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

September 02, 2011

News Conference News

Comprehensive French TAVI Registry Shows Promising Results

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

August 01, 2011

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

News Daily News

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

July 27, 2011

News Daily News

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

July 18, 2011

News Daily News

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

July 05, 2011

News Daily News

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

June 13, 2011

News Daily News

Syntax Score Predicts 1-Year Risk in ACS Patients

June 06, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

L.A. McKeown

May 24, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Daily News

Survey Exposes Conflicted Attitudes Toward Industry Funding of CME

Caitlin E. Cox

May 13, 2011

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

News Daily News

Single-Center Experience Shows Evolution of CoreValve Procedure Over Time

Jason Kahn

April 18, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

News Conference News

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

L.A. McKeown

April 05, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

Advertisement

Two Trials Show Favorable Results with XIENCE V vs. Earlier DES, BMS

Comprehensive French TAVI Registry Shows Promising Results

Long-term Antiplatelet Therapy: All Risk, No Benefit

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Interruption of Antiplatelet Therapy Unnecessary for Tooth Extraction

Prasugrel Fails to Tame Platelets in One-Quarter of ACS Patients Undergoing PCI

Bleeding in ACS Patients Takes Center Stage in ESC Position Paper

One-Month Platelet Reactivity After PCI Key Risk Factor for Future Events

Syntax Score Predicts 1-Year Risk in ACS Patients

EES Show Long-term Safety Advantage over SES

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Survey Exposes Conflicted Attitudes Toward Industry Funding of CME

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

Single-Center Experience Shows Evolution of CoreValve Procedure Over Time

Therapies Take on In-Stent Restenosis with Mixed Results

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content